Content bottom
Result Pages: Previous | 1 | 2 | 3 | 4 | 5 | 6 | 7 | Next | ||||
Date/Time | Subject | Author | ||
---|---|---|---|---|
05-04-17 | ||||
|
||||
|
||||
Continuous buying by Directors and non exec's.
They are certainly aligned with shareholders and appear keen to keep ploughing more in. Confidence maybe? |
||||
14-03-17 | ||||
|
||||
|
||||
I think the RNS of 22nd Feb needs clarification. I think the term tranches is misleading and it has been used just to make it easier to understand. As stated before each note as a nominal value of £10,000, so in the case of the 1st tranche 130 notes were issued. If it goes AVO's way at the GM (existing investors have no choice but to go along with it unless they want to come up with the dosh) it will get 1,300 notes issues (forget the 50% pay back side, just a sweetner) . It has converted 10 notes so far ie £100,000.
It states in the circular Conversion: The Notes must be converted into Ordinary Shares within twelve months of issue at a ConversionPrice equal to the lowest Closing VWAP during the fifteen (15) Trading Days immediatelypreceding the Conversion Date. Upon receipt of a conversion notice from Bracknor, theCompany can elect to redeem up to half (50%) of the Notes which are the subject of the notice byway of a cash payment, instead of converting them into Ordinary Shares. It doesn't state anything about tranches just notes, so yes the notes must be converted into shares in 12 mths. Bracknor is controlling the outcome and it will want to sell shares before converting the notes, if it didn't it would soon be up to 29.9%, which (a) it isn't allowed to and (b) it would have to make a bid for the company, which it definitely doesn't want to do. Which to get back to "Drawdown of a trache of notes cannot be requested by either party without the written consent of the other unless (1) all previously issued notes have been converted in Ord shares" meaning AVO will not be allowed to draw down the next batch of loan notes until Bracknor's say so and that will only occur once it has sold the majority of the converted loans. Personally, shareholders are going to see mega dilution after the GM and if it doesn't insolvency. Why anyone is buying is beyond me |
||||
14-03-17 | ||||
|
||||
|
||||
"Drawdown of a trache of notes cannot be requested by either party without the written consent of the other unless (1) all previously issued notes have been converted in Ord shares"
What I think this says is that AVO have the right to insist that Bracknor convert all previous loan notes before another £1.3m tranche is issued. However, this only applies if one party has not given their written consent to the next drawdown. The mandated conversion is within one year of issue. The document also says this: "Upon receipt of a conversion notice from Bracknor, the Company can elect to redeem up to half (50%) of the Notes which are the subject of the notice by way of a cash payment, instead of converting them into Ordinary Shares." This is really likely to happen, isn't it? A company that is so short of money that they borrow from corporate loan shark, is going to repay 50% in cash, rather than issue more shares. The only way this could happen is if they can borrow money to repay Bracknor, as they are two to three years away from being able to sell a LIGHT machine. |
||||
14-03-17 | ||||
|
||||
|
||||
ps re the conversion the whole 10 tranches need to be converted in the 12 months ie £13m worth. It can delay 2 of these tranches
|
||||
14-03-17 | ||||
|
||||
|
||||
It's confusing. If you look in part II The Facility in the GM circular under timing it states Drawdown of a trache of notes cannot be requested by either party without the written consent of the other unless (1) all previously issued notes have been converted in Ord shares or (ii) a period of 5 days has elapsed since the date of transfer of funds to the company in respect of the previous tranche of note issued.
A note is a CLN each of a nominal value of £10,000 If resolution 1 fails not tranche 2 and I assume the company runs out of cash and thats the end of that |
||||
13-03-17 | ||||
|
||||
|
||||
Spankaroo,
The way I read it is that they have one year to convert loan notes, and 4 years to convert the Warrants. - Minimum of 10 tranches of £1.3 million of convertible loan notes each, with the option - at the Company's sole discretion - to draw down up to 10 additional tranches within two years; - Each tranche must be converted into new or existing shares of the Company within twelve months of issuance ("Conversion Period"); - Upon issuance of a tranche, Bracknor shall receive warrants to purchase shares with an aggregate value equivalent to 20% of the nominal value of each tranche. These warrants will be exercisable for up to four years from issue; AVO cannot draw down the second tranche until they get approval from shareholders at an EGM. |
||||
13-03-17 | ||||
|
||||
|
||||
Still no conversion! Weird, because if I'm reading the conditions of the CLN properly, it has the convert tranche 1 before it can move on to tranche 2. The skeptic in me thinks maybe nothing is going to be converted before the GM to try and keep the share price stable, but that means a lot to be converted in April
|
||||
10-03-17 | ||||
|
||||
|
||||
I'm somewhat surprised Bracknor didn't do a conversion today. I would have through it would have sold quite a few yesterday. Perhaps Monday
|
||||
10-03-17 | ||||
|
||||
|
||||
Familiar AIM story I'm afraid, esp with techie shares - a good product potentially but very badly managed.
What especially put me off AVO was management's over-eagerness to appoint advisers / directors, usually with unjustified remuneration. |
||||
07-03-17 |
2![]() |
|||
|
||||
|
||||
"Low Debt & Good cash reserves. This company seems like it's geared itself well for a prolonged period of limited cash-flow."
Are you having a laugh Oxtrader? There are very good reasons why this share is cheap. This company is so desperate for cash, that they trying to force through a loan deal with a last resort lender, who have a reputation for trashing the share price wherever they invest. AVO are two to three years behind their target date of 2016 for producing a working prototype. So it is not limited cash flow, it is likely to be zero cash flow for all of that time. After all you cannot sell what you cannot produce. Their forward orders have been cancelled due to the failure to give a delivery date, and the company have lied to and misled their shareholders repeatedly. I would advise extreme caution with this stock. There are far safer places to put your money than this. |
||||
07-03-17 | ||||
|
||||
|
||||
Just because share price is crashing doesn't mean the Company will go bankrupt. Just an extremely unattractive investment for the short & medium term.
This has risen to a top faller today, which caught my eye on the Homepage - but having a quick look at the fundamentals - Low Debt & Good cash reserves. This company seems like it's geared itself well for a prolonged period of limited cash-flow. |
||||
07-03-17 | ||||
|
||||
|
||||
Oh No! just realised !
|
||||
07-03-17 | ||||
|
||||
|
||||
and then ?????
|
||||
07-03-17 | ||||
|
||||
|
||||
Why was there big buying?
|
||||
07-03-17 |
3![]() |
|||
|
||||
|
||||
5haggy,
I am not sure there is any hope for the company. To explain, I have copied below a post that I put on the LSE board last night. "Early milestones met to ensure the delivery of the first system in 2016" That quote was from the 2014 Half Yearly Report. Today the company says: "the first LIGHT system is expected to be capable of treating superficial tumours in Q3 2018." So in 18 months time they still will not have a fully working prototype (only one that can treat near surface tumours). And Harley Street has been pushed a long way into the future as well. Even if they can actually achieve the current goals, where is the cash to come from to keep the company running for the next 3 years, before they can actually sell any machines? The fact that they had to borrow from Bracknor, implies that no one else will touch them with a barge pole. The Bracknor loan will not keep the company afloat for very long, and is also likely to seriously depress the sp. The product / idea is great, but the technology is taking far too long to get from the drawing board and into production. And without some serious new funding, time is something that AVO do not have. IMO AVO are going to need a miracle just to survive. |
||||
07-03-17 | ||||
|
||||
|
||||
Well, yesterday's RNS went down like a lead balloon - SP down 25% this morning!
What did the bean-counters see in this RNS that was so bad? Is there any hope for this company? |
||||
23-02-17 |
Sell
Death spiral finance
|
|||
|
||||
|
||||
Obviously Bracknor has yet to get started forward selling, but when it does I wouldn't want to be in this one. Only saving grace is how is it going to sell so many into so little volume. One for the brave
|
||||
09-02-17 | ||||
|
||||
|
||||
Priceless!
Dr Plowman has been rewarded for flouting stock market rules by being appointed a as full Non-Executive Director. |
||||
08-02-17 | ||||
|
||||
|
||||
Directors buys are very positive for a company, but why was this one announced a full 8 months after the event?
AVO have history in this, back in November they announced that Lord Evans had sold all his shares sometime between 1 month to 2 months earlier. This occurred during a closed period according to Tom Winnifrith, and a few days later Lord Evans fell on his sword. Corporate governance does not seem to be a strong point with the board of AVO. |
||||
08-02-17 | ||||
|
||||
|
||||
Dr. N Plowman holds. 2.63m 3.6%
|
||||
07-02-17 |
1![]() |
|||
|
||||
|
||||
I have spoken to AVO and it was an interesting call.
I urge anyone to speak to them as they will try and answer your concerns. I understand that it is disappointing, but if you don't make a statement that you will make the appropriate action, then everyone will say why don't you threaten them with legal action. Damned if you do and damned if you don't. Interesting that you believe Sinophi's statement about, "As a result, Sinophi does not expect there to be any progress with the four Framework Agreements with Chinese hospitals signed in 2015 to use and install Advanced Oncotherapy LIGHT proton therapy machines until such time as Advanced Oncotherapy has a working prototype capable of commercialization. As this is a new technology, still in the research and development stage, we are unable to predict when this will be achieved." The road map that AVO published in 2015 has always been adhered to and we have been kept abreast of progress. Harley street and the plans for that are still on track and we've been promised a more detailed plan in March/April, I can't remember the exact wording we had in December but 100days was mentioned. Sinophi obviously wanted out and only they know why. I'm still confident of AVO and will top up again in April when my ISA allows. GLA |
||||
06-02-17 |
4![]() |
|||
|
||||
|
||||
The reason that I used the term weasel words was due to this ludicrous statement:
"Advanced Oncotherapy is firmly of the view that Sinophi has no legal basis on which to make this termination and will take appropriate action to protect its position." This deal was dead in early November. It was obvious at the time Sinophi would not be able to proceed without the hospitals concerned, that Sinophi were too small to be sued, and that AVO did not have the funds to do so anyway. Yet on the 24th Jan AVO issue the above RNS with the implied threat to sue; as I said pathetic. And no I would not want them to waste money suing Sinophi. What I would like them to do is to cut out the BS and be a lot more honest with their news releases. |
||||
06-02-17 | ||||
|
||||
|
||||
Perhaps AVO are well rid of Sinophi and can now paddle their own canoe.
|
||||
06-02-17 | ||||
|
||||
|
||||
I've emailed them asking for some further info, so we'll see if they come back to me.
|
||||
06-02-17 | ||||
|
||||
|
||||
I think you are over reacting. Of course it isn't the greatest news, but to say pathetic weasel words is probably a bit harsh.
You must remember that they probably did believe they were right, but then in the face of a lengthy legal battle and costs, they probably thought it's not worth the hassle. Cut the ties and move on. Would you prefer them to pursue a legal case? Spend the money they have, potentially go to the market to raise more funds to pay for it? Divert attention and focus on delivering what they have to do? I'd like to know the reasons why, but given the situation I'm not surprised of the stance. |
||||
06-02-17 |
1![]() |
|||
|
||||
|
||||
Fish lips,
The reason that the Sinophi deal collapsed was due to delays in AVO being able to produce a working prototype, or even say when this was likely. As in my previous post AVO have tried to pretend that the deal was still intact, and laughably even threatened to take action against Sinophi. A far more straightforward and honest statement from Sinophi. http://www.sinophi.com/update-on-proton-therapy-projects/ November 26, 2016 "In early November 2016, Sinophi Healthcares two project cooperations with China-Japan Union Hospital of Jilin University and HuaiAn First Peoples Hospital to install Advanced Oncotherapy LIGHT proton therapy machines were terminated due to delays in the proton therapy machine delivery schedules. Sinophi is not looking for other sites for these machines in either Changchun or HuaiAn and will look elsewhere. As a result, Sinophi does not expect there to be any progress with the four Framework Agreements with Chinese hospitals signed in 2015 to use and install Advanced Oncotherapy LIGHT proton therapy machines until such time as Advanced Oncotherapy has a working prototype capable of commercialization. As this is a new technology, still in the research and development stage, we are unable to predict when this will be achieved." |
||||
06-02-17 |
1![]() |
|||
|
||||
|
||||
What pathetic and weasel words from AVO.
After repeatedly denying that the contract had been terminated (the contract exists, but there are no customers), they then threaten to take appropriate action, and finally return all of Sinophi's $250k deposit. When is this company going to stop lying to, and misleading its shareholders? RNS 16th Nov "Separately, the Company has been informed by Sinophi Healthcare Limited ("Sinophi") that Sinophi's customers, will not now be proceeding with the installation of AVO's LIGHT technology in the hospitals of China-Japan Union Hospital of Jilin University in Changchun and First People's Hospital of Huai'An. Advanced Oncotherapy's orders for the two machines from Sinophi remain in place and as per this agreement Sinophi and AVO are assessing other sites in the same cities as well as pursuing other framework agreements in China." RNS 30th Nov "The Company reiterates that despite the recent news that two Chinese customers are not now proceeding with LIGHT installations, the sale and purchase agreements between Sinophi Healthcare Limited and Advanced Oncotherapy for two machines remain in place..... The purchase agreements also state that Sinophi will install the LIGHT system in the specific planned facility sites in Changchun or Huai'An or, if not, in alternative locations in China." RNS 24th Jan "Advanced Oncotherapy is firmly of the view that Sinophi has no legal basis on which to make this termination and will take appropriate action to protect its position." RNS 6th Feb "As a result of the ending of the agreement with Sinophi, Advanced Oncotherapy has repaid the deposit of $250,000 received on 18 September 2015 (recorded in the Annual Report 2015 in Note 21 as Customer order deposits received)." |
||||
06-02-17 |
Hold
Re: RNS
|
|||
|
||||
|
||||
So, Sinophi has fallen through. I wonder why? They must have another supplier. Perhaps a Chinese one!
It is disappointing, but this was just one partner, once this gets going I'd imaging there will be a number of big players that will buy this company. They need to get it fully tested and operational, first though, which is all looking on track. SP has fallen but the market doesn't see this as catastrophic, either, as volume is only small. GLA |
||||
06-02-17 |
1![]() |
|||
|
||||
|
||||
23-01-17 |
1![]() |
|||
|
||||
|
||||
Strategic partner!
Interesting they are still using the term non-dilutive. So who is it going to be? Who ever it is it is good news. Hopefully see a tick up this morning. |
||||
03-01-17 | ||||
|
||||
|
||||
Amen! but they've hardly inested a kings' ransom have they?
what do you calculate their aggregate outlay cf their remuneration? |
||||
03-01-17 |
1![]() |
|||
|
||||
|
||||
So the SP is now recovering and we've had some Director buys. things are looking good for 2017, we just need the thing to work now!
|
||||
02-12-16 | ||||
|
||||
|
||||
Update from Beaufort Securities
https://www.research-tree.com/research/breakfast-today/7841a173-b3ee-4a79-8c7d-e2d8973ecec4 |
||||
01-12-16 | ||||
|
||||
|
||||
I work in a similar industry and, agreed, it is now the key milestone.
The RNS stated that we'll get an update in Q1 next year, that gives them plenty of wriggle room, as I know that Testing can throw up a whole heap of stuff that can scupper a release. |
||||
01-12-16 |
1![]() |
|||
|
||||
|
||||
Fish lips it shows they read the bulletin boards. You mentioned the testing in a previous post. I agree this is an area that investors will be focusing on in the future. It's all very well having nice premises in Harley Street and provisional orders from China but the key to future sales is having a fully working machine up and running with a CE mark.
|
||||
01-12-16 |
1![]() |
|||
|
||||
|
||||
And as if by magic out comes an RNS! Mystic Fishlips!
|
||||
30-11-16 | ||||
|
||||
|
||||
I agree the management need to put some spin on things, the price has dropped because a few people didn't like the news about the Hospital pulling out of the agreement. The end user has still agreed to take the units, but, at this moment they don't have a location anymore. So the MM will have offered a low price and the seller has taken it and that's driven the SP down.
Is the news significant, it depends on how you view it. It is disappointing, but not the end of the world. It's the testing and how that is going that is the major news item we need to know. Good to see a director buying more. |
||||
29-11-16 |
1![]() |
|||
|
||||
|
||||
I don't hold these but can't help noticing the awful chart. The shares have been slipping on modest volume without much buying interest. The cash burn in the first half wasn't encouraging either.
Management need to do something to rebuild confidence. |
||||
25-10-16 |
1![]() |
|||
|
||||
|
||||
https://www.youtube.com/watch?v=9GwgXwKekBc
Mmnn |
||||
20-10-16 | ||||
|
||||
|
||||
Already took it up and put down for a grand more if they're available. I have a conservative figure of £5 if all goes well. But if it does go well I'm sure they'd be bought out.
|
||||
Result Pages:
Previous |
1 |
2 |
3 |
4 |
5 |
6 |
7 |
Next
Search archive
|
||||
![]() |
Important message from the Financial Conduct Authority:
Posting inside information that is not public knowledge, or information that is false or misleading, may constitute market abuse.
This could lead to an unlimited fine and up to seven years in prison.
If you have any information, concerns or queries about market abuse, click here.
The content of the messages posted represents the opinions of the author, and does not represent the opinions of Interactive Investor Trading Limited or its affiliates and has not been approved or issued by Interactive Investor Trading Limited.
You should be aware that the other participants of the above discussion group are strangers to you and may make statements which may be misleading, deceptive or wrong.
Please remember that the value of investments or income from them may go down as well as up and that the past performance of an investment is not a guide to its performance in the future.
The discussion boards on this site are intended to be an information sharing forum and is not intended to address your particular requirements. Whilst information provided on them can help with your investment research you need to consider carefully whether you should make (or refraining from making) investment or other decisions based on what you see without doing further research on investments you are interested in. Participating in this forum cannot be a substitute for obtaining advice from an appropriate expert independent adviser who takes into account your circumstances and specific investment needs in selected investments that are appropriate for you.
The discussion boards on this site are intended to be an information sharing forum and is not intended to address your particular requirements. Whilst information provided on them can help with your investment research you need to consider carefully whether you should make (or refraining from making) investment or other decisions based on what you see without doing further research on investments you are interested in. Participating in this forum cannot be a substitute for obtaining advice from an appropriate expert independent adviser who takes into account your circumstances and specific investment needs in selected investments that are appropriate for you.
Navigation bar
- Our Services
- Our Accounts
- Investment Products
- Advanced Products
- Your Goals
- Investment Ideas
- Shares & Companies
- Funds & Investment Trusts
- Investment Options
- Research Tools
- News
- Search by Sector
- Search by Manager Group
- News & Research
- Markets News
- Company Analysis
- Company Research
- Learning
- iiTV
- Discussions
- Discussion boards
Right sidebar